Damian Sousa »

Taysha Gene Therapies shares owned by Damian Sousa

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Damian Sousa from 13F filings

Historical chart of Damian Sousa investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Damian Sousa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Damian Sousa

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.1M 1.8M 2.84

More positions owned by Damian Sousa

Microsoft Corp Common Stock (MSFT)
Synopsys Common Stock (SNPS)
Broadcom Common Stock (AVGO)
Rb Global Common Stock (RBA)
Crowdstrike Holdings Inc - A Common Stock (CRWD)
Dexcom Common Stock (DXCM)
Chevron Corp Common Stock (CVX)
Jpmorgan Chase & Co Common Stock (JPM)
Celsius Holdings Common Stock (CELH)
Waste Connections Common Stock (WCN)
Baker Hughes Common Stock (BKR)
Entegris Common Stock (ENTG)
Ross Stores Common Stock (ROST)
Wabtec Corp Common Stock (WAB)
Merck & Co Common Stock (MRK)

View all positions for Damian Sousa

Top funds holding Taysha Gene Therapies

FMR
RA Capital Management
VR Adviser
Vanguard Group
Morgan Stanley
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Octagon Capital Advisors
BlackRock
Damian Sousa
Cowen And Company
Susquehanna International
Point72 Asset Management

View all funds holding Taysha Gene Therapies